Expression of vascular endothelial growth factor (VEGF)‐C and VEGF‐D, and their receptor VEGFR‐3, during different stages of cervical carcinogenesis
- 26 September 2003
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 201 (4) , 544-554
- https://doi.org/10.1002/path.1467
Abstract
Cervical carcinogenesis has well-defined stages of disease progression including three grades of pre-invasive lesions—cervical intraepithelial neoplasia grades 1–3 (CIN 1–3)—and invasive cervical cancer. However, the biological properties of CIN lesions prone to develop invasive disease are not well defined. Recent observations suggest that early invasive disease spreads to regional lymph nodes in several tumour types and that growth factors (VEGF-C and VEGF-D) involved in new lymphatic vessel formation may play a crucial role in this process. The present study has assessed the expression of VEGF-C and VEGF-D, and their receptor VEGFR-3, in 152 cervical lesions (33 CIN 1, 33 CIN 2, 37 CIN 3, and 49 squamous cell carcinomas) to determine whether expression of lymphangiogenic factors occurs prior to invasion. The presence of lymphatic vessels was determined using LYVE-1 and podoplanin staining, as well as double immunostaining for LYVE-1/CD34 and podoplanin/CD34. In situ hybridization was performed to determine VEGFR-3 mRNA expression. A significant positive correlation was found between VEGF-C, VEGF-D, and VEGFR-3 expression through the different stages of cervical carcinogenesis. Significant differences in protein expression for VEGF-C, VEGF-D, and VEGFR-3 were found between CIN 1–2 and CIN 3 (p < 0.001 for all), but not between CIN 3 and cervical cancer. More than 50% of the CIN 3 lesions showed moderate to strong staining for VEGF-C and VEGF-D, whereas most of the early pre-cancerous lesions (CIN 1 and 2) were negative. In cervical cancer, similar observations to those in CIN 3 were found. VEGFR-3 mRNA expression was found in the cytoplasm of epithelial neoplastic cells and VEGFR3 protein expression was found in more than 50% of CIN 3 lesions and cervical cancers, compared with 15% in CIN 1 and 2. These findings suggest an autocrine growth stimulation pattern via VEGFR-3. Adjacent CIN 3 was present in nine cervical cancers and displayed strong expression for VEGF-C, VEGF-D, and VEGFR-3. These results suggest that in cervical carcinogenesis a switch to the lymphangiogenic phenotype may occur at the stage of CIN 3. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 39 references indexed in Scilit:
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Molecular quantification and mapping of lymph-node micrometastases in cervical cancerThe Lancet, 2001
- Angiogenesis Modulators Expression in Culture Cell Lines Positives for HPV-16 OncoproteinsBiochemical and Biophysical Research Communications, 2000
- Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular TumorsThe American Journal of Pathology, 1998
- Papillomavirus infections — a major cause of human cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Vascular Permeability Factor (Vascular Endothelial Growth Factor) Expression and Angiogenesis in Cervical NeoplasiaJNCI Journal of the National Cancer Institute, 1995
- Basement membrane and extracellular interstitial matrix components in bladder neoplasia—evidence of angiogenesisHistopathology, 1994
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary HyperplasiaScience, 1977